20-Year Pro Trader Reveals His "MoneyLine"
Ditch your indicators and use the "MoneyLine." A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.
Someone with a lot of money to spend has taken a bullish stance on Regeneron Pharmaceuticals (NASDAQ:REGN).
And retail traders should know.
We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.
Whether this is an institution or just a wealthy individual, we don't know. But when something this big happens with REGN, it often means somebody knows something is about to happen.
So how do we know what this whale just did?
Today, Benzinga's options scanner spotted 18 uncommon options trades for Regeneron Pharmaceuticals.
This isn't normal.
The overall sentiment of these big-money traders is split between 66% bullish and 33%, bearish.
Out of all of the special options we uncovered, 5 are puts, for a total amount of $302,280, and 13 are calls, for a total amount of $823,930.
What's The Price Target?
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $690.0 to $900.0 for Regeneron Pharmaceuticals over the last 3 months.
Volume & Open Interest Development
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Regeneron Pharmaceuticals's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Regeneron Pharmaceuticals's whale trades within a strike price range from $690.0 to $900.0 in the last 30 days.
Regeneron Pharmaceuticals Option Volume And Open Interest Over Last 30 Days
Biggest Options Spotted:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|
| REGN | CALL | SWEEP | BULLISH | 01/17/25 | $690.00 | $455.7K | 0 | 18 |
| REGN | PUT | TRADE | BEARISH | 01/17/25 | $780.00 | $106.8K | 5 | 11 |
| REGN | PUT | TRADE | NEUTRAL | 01/19/24 | $740.00 | $99.3K | 93 | 20 |
| REGN | CALL | TRADE | BULLISH | 06/30/23 | $740.00 | $42.0K | 40 | 36 |
| REGN | PUT | TRADE | BULLISH | 06/30/23 | $740.00 | $37.9K | 52 | 23 |
Where Is Regeneron Pharmaceuticals Standing Right Now?
- With a volume of 287,045, the price of REGN is up 1.15% at $748.49.
- RSI indicators hint that the underlying stock is currently neutral between overbought and oversold.
- Next earnings are expected to be released in 58 days.
What The Experts Say On Regeneron Pharmaceuticals:
- RBC Capital downgraded its action to Sector Perform with a price target of $811
- Guggenheim has decided to maintain their Buy rating on Regeneron Pharmaceuticals, which currently sits at a price target of $935.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Regeneron Pharmaceuticals, Benzinga Pro gives you real-time options trades alerts.
20-Year Pro Trader Reveals His "MoneyLine"
Ditch your indicators and use the "MoneyLine." A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!